Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Could Investing in Vaxart Make You a Millionaire?
11:43am, Wednesday, 01'st Jul 2020
Thanks to its innovative vaccine technology platform and recently fast-tracked COVID-19 vaccine candidate, Vaxart is likely a millionaire-maker stock.
Is It Too Late to Buy Vaxart Stock?
06:55am, Tuesday, 30'th Jun 2020
This 20-bagger just might still have room to run. But its risks are ginormous.
Vaxart's Oral Coronavirus Vaccine Candidate Gets Chosen by OWS
12:42pm, Monday, 29'th Jun 2020
Vaxart's (VXRT) oral COVID-19 vaccine candidate is picked for a non-human primate challenge study as part of the Operation Warp Speed initiative to rapidly develop a vaccine against SARS-CoV-2.
Why Vaxart Shares Are Vaulting Higher Again
12:33pm, Monday, 29'th Jun 2020
Momentum from last week's big news continues.
Coronavirus vaccine: Vaccine is still 'a long way away,': Dr. Dara Kass
10:59am, Monday, 29'th Jun 2020
Dr. Dara Kass, an associate professor of emergency medicine at Columbia University, breaks down Remdesivir pricing from Gilead for treatment of COVID-19.
2 Biotech Stocks That Rocketed Higher Last Week
09:13am, Monday, 29'th Jun 2020
After an unbelievable week, Investors want to know if these drugmakers have what it takes to keep climbing.
Better Coronavirus Stock: VBI Vaccines or Vaxart?
08:12am, Saturday, 27'th Jun 2020
A company's vaccine manufacturing capabilities can make a world of difference.
Smart Investors Might Consider Buying This Coronavirus Stock That Just Popped 96%
08:08am, Saturday, 27'th Jun 2020
Vaxart’s aggressive moves to scale up its vaccine-manufacturing capabilities bode well for the company’s future.
Covid Report: Tiny Biotech Stock Catapults 28% As Feds Eye Its Vaccine
04:58pm, Friday, 26'th Jun 2020
Vaxart stock rocketed Friday after the federal government selected its coronavirus vaccine for the Operation Warp Speed program. Translate Bio stock, however, fell on a public offering.
Why Vaxart Stock Skyrocketed Today
01:37pm, Friday, 26'th Jun 2020
The coronavirus vaccine maker will participate in a government-funded study.
Vaxart Rallies On Double Dose Of Positive Coronavirus Vaccine Developments
09:25am, Friday, 26'th Jun 2020
Shares of oral vaccine maker Vaxart Inc (NASDAQ: VXRT) are on a strong two-day run after two announcements tied to coronavirus vaccine development.
Vaxart shares skyrocket on news its COVID-19 vaccine candidate to be part of 'Operation Warp Speed'
08:09am, Friday, 26'th Jun 2020
Vaxart Inc. VXRT, +96.23% said Friday its oral COVID-19 vaccine has been selected to take part in a non-human primate challenge study funded by the U.S.
Vaxart’s COVID-19 Vaccine Selected for the U.S. Government’s Operation Warp Speed
08:00am, Friday, 26'th Jun 2020
OWS to Test First Oral COVID-19 Vaccine in Non-Human Primates OWS to Test First Oral COVID-19 Vaccine in Non-Human Primates
Why Vaxart, Inovio, and Sorrento Therapeutics Stocks Soared Today
06:12pm, Thursday, 25'th Jun 2020
Investors are piling into coronavirus stocks as COVID-19 cases surge.
Vaxart, Inc. Signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP
08:00am, Thursday, 25'th Jun 2020
Enabling Production of A Billion or More COVID-19 Vaccine Doses Per Year
